Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes

Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes

Development of the 4-component meningococcal serogroup B vaccine (4CMenB) has required new assays for the reliable evaluation of the expression and cross-reactivity of those specific antigen variants that are predicted to be targeted by bactericidal antibodies elicited by the vaccine in different is...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alexander Domnich, Roberto Gasparini, Daniela Amicizia, Giuseppe Boccadifuoco, Marzia Monica Giuliani, Donatella Panatto
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2015/353461
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epidemiological Characteristics of Meningococcal Meningitis (2016 to 2018) Four Years after the Introduction of Serogroup A Meningococcal Conjugate Vaccine in Benin
by: Togbemabou Primous Martial Godjedo, et al.
Published: (2020-01-01)

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers
by: Susanna Esposito, et al.
Published: (2015-01-01)

Meningococcal Disease: Facts versus Fiction
by: R Gold
Published: (1992-01-01)

Primary Meningococcal Polyarthritis in an Adult Woman
by: José Celso Giordan Cavalcanti Sarinho, et al.
Published: (2015-01-01)

Are Physicians Obligated to Tell Parents about the Meningococcal Serogroup B Vaccine?
by: Dr Joan L Robinson
Published: (2015-01-01)

Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection
by: Nicole Le Saux, et al.
Published: (2009-01-01)

The effect of meningococcal vaccines on new generation of systemic inflammatory markers in children
by: Omer Okuyan, et al.
Published: (2025-01-01)

Effect of Hemoadsorption for Cytokine Removal in Pneumococcal and Meningococcal Sepsis
by: Francesca Leonardis, et al.
Published: (2018-01-01)

Bilateral Renal Cortical Necrosis in Meningococcal Meningitis
by: C. Kennedy, et al.
Published: (2011-01-01)

Multilocus Enzyme Electrophoresis – Application to the Study of Meningococcal Meningitis and Listeriosis
by: FE Ashton
Published: (1990-01-01)

Carriage of Neisseria Species in Communities with Different Rates of Meningococcal Disease
by: Nicole Le Saux, et al.
Published: (1992-01-01)

Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis
by: F. Staels, et al.
Published: (2022-01-01)

Risk and Prevention of Meningococcal Disease among Education Workers: A Review
by: Philippe De Wals, et al.
Published: (2004-01-01)

A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine
by: Imran Khan, et al.
Published: (2016-01-01)

Primary Meningococcal Type C Arthritis: A Case Report and Literature Review
by: Maximiliano Barahona, et al.
Published: (2017-01-01)

Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit
by: Eylem Kiral, et al.
Published: (2021-01-01)

Meningococcal Neonatal Purulent Conjunctivitis/Sepsis and Asymptomatic Carriage of N. meningitidis in Mother’s Vagina and Both Parents’ Nasopharynx
by: Enrique Chacon-Cruz, et al.
Published: (2017-01-01)

Usefulness of Pulsed-Field Gel Electrophoresis in Tracking Two Outbreaks of Invasive Meningococcal Disease Serogroup C in British Columbia
by: Grahame Quan, et al.
Published: (2007-01-01)

G1 Cell Cycle Arrest Is Induced by the Fourth Extracellular Loop of Meningococcal PorA in Epithelial and Endothelial Cells
by: Matthew Vassey, et al.
Published: (2023-01-01)

Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01)

Estimation of the incidence of invasive meningococcal disease using a capture–recapture model based on two independent surveillance systems in Catalonia, Spain
by: Pilar Ciruela, et al.
Published: (2022-06-01)

Evaluating the Efficacy of a Serious Game to Deliver Health Education About Invasive Meningococcal Disease: Clustered Randomized Controlled Equivalence Trial
by: Lauren Bloomfield, et al.
Published: (2025-02-01)

Potential Capsule Switching from Serogroup Y to B: The Characterization of Three such Neisseria meningitidis Isolates Causing Invasive Meningococcal Disease in Canada
by: Raymond SW Tsang, et al.
Published: (2005-01-01)

Characterization of Serogroup A Neisseria meningitidis from Invasive Meningococcal Disease Cases in Canada Between 1979 and 2006: Epidemiological Links to Returning Travellers
by: Angela M Sloan, et al.
Published: (2008-01-01)

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines
by: R. Gasparini, et al.
Published: (2015-01-01)

Welfare of horses during killing for purposes other than slaughter
by: EFSA AHAW Panel (EFSA Panel on Animal Health and Welfare), et al.
Published: (2025-01-01)

Academic Writing for Publication Purposes and Machine Translation: Is the Symbiosis Possible?
by: O. L. Dobrynina
Published: (2022-01-01)

Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
by: Petr G. Lokhov, et al.
Published: (2016-01-01)

Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines
by: Aziz A. Chentoufi, et al.
Published: (2024-12-01)

Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
by: Renee Vermeij, et al.
Published: (2010-01-01)

Competitive purposefulness
by: O. V. Mikhailov
Published: (2019-04-01)

Purpose and practice
by: Sonja Verwey, et al.
Published: (2022-10-01)

Inonotus hispidus (Bull.) P. Karst. - bioecological characteristics, significance and possibility of use for medical purposes (medicinal properties)
by: Radulović Zlatan, et al.
Published: (2024-01-01)

Chemical cross‐linking facilitates antigen uptake and presentation and provides improved protection from Mpox with a dual‐antigen subunit vaccine
by: Long Chen, et al.
Published: (2025-01-01)

Effects of different vaccination regimes on the immunodiagnosis of tuberculosis in goats and evaluation of defined antigens
by: Patricia Cuenca-Lara, et al.
Published: (2025-01-01)

Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen
by: Yu-Chan Chih, et al.
Published: (2025-02-01)

Problematic Issues of Calculating the Size of Damage from the Use of Land Plots for Other Purposes within the Practice of Law Enforcement Agencies
by: I. V. Bryhadyr, et al.
Published: (2021-03-01)

Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
by: Boya Zhong, et al.
Published: (2015-01-01)

ANTIGENIC AND PROTECTIVE PROPERTIES OF EXPERIMENTAL ASSOCIATED VIRUS VACCINE AGAINST SHEEP POX AND GOAT POX
by: A. V. Konstantinov, et al.
Published: (2018-07-01)

Leaf-Encapsulated Vaccines: Agroinfiltration and Transient Expression of the Antigen Staphylococcal Endotoxin B in Radish Leaves
by: Pei-Feng Liu, et al.
Published: (2018-01-01)